These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 553542)

  • 1. [Degradation products of fibrinogen in synovial fluid].
    Punzi L; Bertaglia E; Pengo V; Fiocco U; Todesco S
    Boll Soc Ital Biol Sper; 1979 Aug; 55(16):1576-80. PubMed ID: 553542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selected indicators of blood coagulation and fibrinolysis in articular exudates of patients with rheumatoid arthritis].
    Dmoszyńska-Giannopoulou A; Kowalewski J; Pytko H; Szczepański L
    Reumatologia; 1979; 17(2):157-60. PubMed ID: 472525
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinogen/fibrin degradation products in exudates from bullous dematoses.
    Mortensen T; Clemmensen I; Søndergaard J
    Acta Derm Venereol; 1979; 59(4):293-6. PubMed ID: 92141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of serum and synovial fluid fibrin degradation products (FDP) estimation in rheumatoid arthritis.
    Gulati PD; Sood KC; Saha K; Kumar A; Zizvi SN
    J Assoc Physicians India; 1982 Nov; 29(11):903-6. PubMed ID: 7130107
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the fibrin degradation products in the synovial fluid of rheumatological diseases (author's transl)].
    Kolodie L; Phelipp X; Baccard C
    Sem Hop; 1980 May 8-15; 56(17-18):832-6. PubMed ID: 6248965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Time-dependent flow behavior and fibrinogen content of synovial fluid].
    Altmann S; Regul M; Zeidler H; Hartmann F
    Z Rheumatol; 1985; 44(2):64-71. PubMed ID: 2931914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis].
    Erov NK
    Ter Arkh; 1986; 58(7):73-7. PubMed ID: 2945279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative detection of keratan sulfate specific epitopes in synovial fluid in inflammatory and degenerative joint diseases].
    Pavelka K; Seibel MJ
    Z Rheumatol; 1989; 48(6):294-300. PubMed ID: 2533769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid composition of the tissues of human knee joints. II. Synovial fluid in trauma.
    Rabinowitz JL; Gregg JR; Nixon JE
    Clin Orthop Relat Res; 1984 Nov; (190):292-8. PubMed ID: 6488646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    J Lab Clin Med; 1978 Nov; 92(5):678-89. PubMed ID: 712203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levels of hormones in plasma and in synovial fluid of knee joint of patients with rheumatoid arthritis].
    Macho L; Rovenský J; Rádiková Z; Imrich R; Greguska O; Vigas M
    Cas Lek Cesk; 2007; 146(3):292-6. PubMed ID: 17419316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activator activity of the synovial fluid as an indicator of activation phenomena in degenerative joint diseases].
    Lindenhayn K; Heilmann HH; Regling G; Haupt R
    Z Rheumatol; 1989; 48(5):246-53. PubMed ID: 2609796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint capsular stiffness in knee arthritis. Relationship to intraarticular volume, hydrostatic pressures, and extensor muscle function.
    Geborek P; Moritz U; Wollheim FA
    J Rheumatol; 1989 Oct; 16(10):1351-8. PubMed ID: 2810260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.
    Carsons S; Mosesson MW; Diamond HS
    Arthritis Rheum; 1981 Oct; 24(10):1261-7. PubMed ID: 6975631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum].
    Takahashi M; Yoshida K; Kano K; Machida T; Nakamura Y; Miura Y; Miura N; Kanno S
    Gan No Rinsho; 1986 Dec; 32(15):1945-9. PubMed ID: 3806965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma and synovial fibronectin. Results of personal research].
    Lecocq J; North ML; Grange D; Hauptmann G; Kuntz JL; Meyer R; Asch L
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):393-8. PubMed ID: 6494778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases].
    Egg D; Günther R; Herold M; Kerschbaumer F
    Z Rheumatol; 1980; 39(5-6):170-5. PubMed ID: 7415586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal concentration in synovial fluids of patients with prosthetic knee arthroplasty.
    Cracchiolo A; Revell P
    Clin Orthop Relat Res; 1982 Oct; (170):169-74. PubMed ID: 7127943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic efficacy of estimating fibrinogen/fibrin degradation products in pleural and peritoneal effusion fluids.
    Dube B; Narayanan R; Dube RK; Singh VP
    J Assoc Physicians India; 1984 Jun; 32(6):493-5. PubMed ID: 6511725
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.